http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more therapy-related complications and higher costs. St. Jude Children's Research Hospital investigators played an important role in the study. http://medicalxpress.com/news/2013-03-cancer-drug-shortages-higher-greater.html Cancer Thu, 21 Mar 2013 11:40:03 EST news283084795 (Medical Xpress)—Researchers from Roswell Park Cancer Institute (RPCI) have published findings from a preclinical study assessing the effectiveness of a small-molecule inhibitor, CFAK-Y15, in treating some brain cancers. The paper, published in Molecular Cancer Therapeutics, demonstrates for the first time that inhibiting the protein focal adhesion kinase (FAK) with CFAK-Y15 is an effective approach to controlling growth of glioblastoma tumors, especially in combination with the standard chemotherapy agent temozolomide (Temodar). http://medicalxpress.com/news/2012-12-fak-inhibitor-effective-brain-tumors.html Cancer Mon, 24 Dec 2012 07:40:26 EST news275557166 A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ASH Annual Meeting and Exposition. http://medicalxpress.com/news/2012-12-weekly-dose-drug-side-effects.html Cancer Tue, 11 Dec 2012 13:05:55 EST news274453533 Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments. http://medicalxpress.com/news/2012-12-pre-clinical-angiocidin-effective-leukemia.html Cancer Sun, 09 Dec 2012 03:30:01 EST news274244028 Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival. This study was presented today by Peter A. Kaufman, M.D., during the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. http://medicalxpress.com/news/2012-12-standard-treatment-women-breast-cancer.html Cancer Fri, 07 Dec 2012 10:40:18 EST news274098654 A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer. http://medicalxpress.com/news/2012-11-success-therapy-common-non-small-cell.html Cancer Wed, 28 Nov 2012 13:35:43 EST news273332135 A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical trials, according to Penn State College of Medicine researchers. http://medicalxpress.com/news/2011-06-breast-cancer-drug-colon-cells.html Cancer Wed, 08 Jun 2011 14:00:01 EST news226756743 (Medical Xpress) -- Tiny tumor proteins circulating in blood may be used to identify which pancreatic cancer patients would benefit from the drug Avastin, researchers at Duke University Medical Center have found. http://medicalxpress.com/news/2011-06-blood-proteins-vulnerability-pancreatic-cancers.html Cancer Tue, 07 Jun 2011 08:47:17 EST news226655214